Alpha 2.0
Login Register
» Authors » David Paculdo

David Paculdo

Explore the profile of David Paculdo including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 150
Followers 0
Related Specialties
General Medicine
Health Services
Cardiology & Vascular Diseases
Top 10 Co-Authors
John Peabody
John W Peabody
Czarlota Valdenor
Mary Tran
Diana Tamondong-Lachica
Enrico de Belen
Divya Ganesan
Joshua Schrecker
Trever Burgon
Rebecca Heltsley
Published In
Diagnostics (Basel)
J Am Heart Assoc
Am J Clin Oncol
Int Urol Nephrol
Healthcare (Basel)
Affiliations
Soon will be listed here.
Recent Articles
1.
Impact of medication nonadherence and drug-drug interaction testing on the management of primary care patients with polypharmacy: a randomized controlled trial
David R, Ferrara K, Schrecker J, Paculdo D, Johnson S, Bentley-Lewis R, et al.
BMC Med . 2024 Nov; 22(1):540. PMID: 39551766
Background: Clinical management of patients with chronic cardiometabolic disease is complicated by polypharmacy. Consequently, when patients clinically deteriorate, physicians are challenged to distinguish both medication nonadherence and drug-drug interactions (DDI)...
2.
A Randomized Controlled Study on Clinical Adherence to Evidence-Based Guidelines in the Management of Simulated Patients With Barrett's Esophagus and the Clinical Utility of a Tissue Systems Pathology Test: Results From Q-TAB
Peabody J, Cruz J, Ganesan D, Paculdo D, Critchley-Thorne R, Wani S, et al.
Clin Transl Gastroenterol . 2023 Sep; 15(1):e00644. PMID: 37767993
Introduction: Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma. Physicians infrequently adhere to guidelines for managing BE, leading to either reduced detection of dysplasia or inappropriate re-evaluation. Methods: We...
3.
Clinical utility of a novel test for assessing cardiovascular disease risk in type 2 diabetes: a randomized controlled trial
Peabody J, Paculdo D, de Belen E, Ganesan D, Cooney I, Trujillo N
Diabetol Metab Syndr . 2023 Jul; 15(1):155. PMID: 37438853
Background: The risk for and treatment of cardiovascular disease (CVD) in type 2 diabetes (T2DM) is often incorrect and delayed. We wished to determine if a novel test improved physicians'...
4.
Clinical Variation in the Treatment Practices for Patients With Type 2 Diabetes: A Cross-Sectional Patient Simulation Study Among Primary Care Physicians and Cardiologists
de Belen E, Ganesan D, Paculdo D, Gill R, Peabody J
J Am Heart Assoc . 2023 Jun; 12(13):e028634. PMID: 37382120
Background Cardiovascular disease risk stratification is necessary and critically important in patients with type 2 diabetes. Despite its known benefits to guide treatment and prevention, we hypothesized that providers do...
5.
Randomized prospective trial to detect and distinguish between medication nonadherence, drug-drug interactions, and disease progression in chronic cardiometabolic disease
Peabody J, Ganesan D, Valdenor C, Paculdo D, Schrecker J, Westerfield C, et al.
BMC Prim Care . 2023 Apr; 24(1):100. PMID: 37061690
Background: Disentangling nonadherence (NA), drug-drug interactions (DDIs), and disease progression from each other is an important clinical challenge for providers caring for patients with cardiometabolic diseases. NAs and DDIs are...
6.
Gaps in the Care of Pulmonary Hypertension: A Cross-Sectional Patient Simulation Study Among Practicing Cardiologists and Pulmonologists
de Belen E, McConnell J, Elwing J, Paculdo D, Cabaluna I, Linder J, et al.
J Am Heart Assoc . 2023 Jan; 12(2):e026413. PMID: 36628980
Background Diagnosis of pulmonary hypertension (PH) is often delayed or missed, leading to disease progression and missed treatment opportunities. In this study, we measured variation in care provided by board-certified...
7.
Clinical variation in surveillance and management of Barrett's esophagus: A cross-sectional study of gastroenterologists and gastrointestinal surgeons
Cruz J, Paculdo D, Ganesan D, Baker M, Critchley-Thorne R, Shaheen N, et al.
Medicine (Baltimore) . 2023 Jan; 101(51):e32187. PMID: 36595793
Appropriate surveillance and treatment of Barrett's esophagus (BE) is vital to prevent disease progression and decrease esophageal adenocarcinoma (EAC)-related mortality. We sought to determine the variation in BE care and...
8.
Clinical Variation in the Treatment Practices for Medication Nonadherence, Drug-Drug Interactions, and Recognition of Disease Progression in Patients with Chronic Cardiometabolic Diseases: A Cross-Sectional Patient Simulation Study among Primary...
Valdenor C, Ganesan D, Paculdo D, Schrecker J, Heltsley R, Westerfield C, et al.
Int J Clin Pract . 2022 Aug; 2022:6450641. PMID: 35989865
Background: Medication nonadherence in patients with chronic diseases is common, costly, and often underdiagnosed. In the United States, approximately 40-50% of patients with cardiometabolic conditions are not adherent to long-term...
9.
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures
Peabody J, Paculdo D, Valdenor C, McCullough P, Noiri E, Sugaya T, et al.
Cardiorenal Med . 2022 Jan; 12(1):11-19. PMID: 35034025
Introduction: Contrast-induced acute kidney injury (CI-AKI) is a major clinical complication of percutaneous cardiovascular procedures requiring iodinated contrast. Despite its relative frequency, practicing physicians are unlikely to identify or treat...
10.
Measuring and Improving Evidence-Based Patient Care Using a Web-Based Gamified Approach in Primary Care (QualityIQ): Randomized Controlled Trial
Burgon T, Casebeer L, Aasen H, Valdenor C, Tamondong-Lachica D, de Belen E, et al.
J Med Internet Res . 2021 Dec; 23(12):e31042. PMID: 34941547
Background: Unwarranted variability in clinical practice is a challenging problem in practice today, leading to poor outcomes for patients and low-value care for providers, payers, and patients. Objective: In this...